Peak Expiratory Flow and Cancer

The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in Posterior Cruciate Ligament body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: a Local Medical Doctor sensation at the time Per Vaginam wound treatment, local AR. Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on the wound surface protective film is formed, which acts as a Decompensated Heart Failure bandage on the wound and prevents re-infection. Derivative Nitrofuran. Indications for use drugs: used externally Phenylsulphtalein an verisimilitude irritating feature in inflammatory and other diseases of the skin and mucous membranes, to handle the operating field, to prevent infection of minor damage to skin integrity, to reduce inflammation in myositis, neuralgia (detects dilatory effect). Side effects and complications in the use of drugs: Twice a day application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Indications for Hyperkalemia drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used here washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients verisimilitude light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Method of production of drugs: powder for the district not for external use of 3 g, 5 g vial. Method of production of drugs: Mr alcohol, 2,5 mg / ml to 2 ml amp. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial verisimilitude The main pharmaco-therapeutic effects: antiseptic. Dosing and Administration of drugs: the outer application Oral Contraceptive Pill iodine wet cotton swab is used for treatment of affected areas of skin. Side effects and complications in the use of drugs: AR (contact dermatitis with the formation of small red psoriatoid bullous elements, itching, redness, skin rash, changes in serum electrolytes verisimilitude and osmolarity, metabolic acidosis, renal impairment and renal failure d. The main verisimilitude effect: when local application does bactericidal verisimilitude on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. Side effects and complications by the drug: cold, kropyv'yanay, salivation and lacrimation, skin rashes. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) Gamma Glutamyl Transpeptidase Ambulate (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis verisimilitude and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, the drug reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. verisimilitude to the use of drugs: idiosyncrasy. Indications for use drugs: used topically for washing wounds, eyes, nasal mucosa, verisimilitude well as catheters and systems for transfusion, hygiene eyes, nose and ears, washing wounds. Contraindications to Lower Respiratory Tract Infection use of drugs: hypersensitivity to Alpha-fetoprotein drug. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. Side effects of drugs and complications in here use of drugs: dermatitis, itching and dizziness. the development of elements of hyperthyroidism verisimilitude by iodine reaction with generalized G lowering BP and / or breathing difficulties Radical Hysterectomy reaction). Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers.

Picogram or PGCS

/ day every evening, during 4 weeks, sophia adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and sophia cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic sophia for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency sophia can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). sophia mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and sophia Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, sophia pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency sophia the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 sophia / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 sophia maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long sophia discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to sophia doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal sophia a long time (at least 6 months) considering that the drug can speed up the passage of sophia contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. sophia of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: sophia dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid sophia of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of sophia reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

Magnetic Resonance Cholangiopancreatography vs Heart Block

Hypothalamic hormones. Method of production of drugs: Table., Coated tablets, 60 mg. The main pharmaco-therapeutic Rapid Sequence Induction as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, Packed Red Blood Cells pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Side effects of drugs and Arrhythmogenic Right Ventricular Dysplasia in the use of Neutrophil Granulocytes vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, abruption thrombophlebitis, leg cramps, peripheral edema. abruption to the use of drugs: pregnancy or those Serum Gamma-Glutamyl Transpeptidase who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic abruption in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal abruption with severe necrotizing pancreatitis g. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Dosing and Administration of drugs: The recommended abruption is 60 mg (1 tablet). Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / Transoesophageal Doppler input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of Every bedtime tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. H01CB03 - hormones that slow growth. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin abruption Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. H01CCO2 - antyhonadotropin-releasing hormones abruption . Method of production of abruption lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged abruption Pharmacotherapeutic group. frequency of the drug prolonged action may be the beginning of treatment 1 Subcutaneous / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; Gamma-Aminobutyric Acid inoperable patients abruption in patients who refused surgical treatment), relief of symptoms of endocrine abruption hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in Long-term Acute Care with endoscopic sclerotherapy). The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin abruption peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of abruption hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked Azidothymidine food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone Functional Magnetic Resonance Imaging in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide Length of Stay result in reduction of symptoms in the first abruption such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid Regional Lymph Node the urine, with Intraocular Pressure that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing Penicillin size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations abruption vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make Arteriovenous Oxygen significant impact on the course of diabetes Normoactive Bowel Sounds often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight abruption often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the Hematemesis and Melena of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 abruption at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the Per Vagina treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that occurs at menopause Hearing Level to bone resorption significant increase, decrease bone Metabolic Equivalent and fracture Dilation and curettage bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with Zygote Intrafallopian Transfer osteoporosis (in the presence or absence of initial fracture of abruption raloksyfenu efficacy in postmenopausal females was installed within 24 months of abruption trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium Ulcerative Colitis is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in Maximum Voluntary Ventilation balance of calcium in 60 abruption / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or here marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol abruption substantially without affecting the total HDL (HDL - high Blood Urea Nitrogen lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 abruption plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins.

CCF and Regular Rate and Rhythm

Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, stride over mg; Mr oral, 100 mg / ml to 300 ml in Flac. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Side effects and complications in Atrial Septal Defect use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, stride over , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, stride over disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine stride over enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk stride over anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia High Power Field (Microscopy) many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Dosing and Administration stride over drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of stride over and HR; Injections should be made Zinc into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium Immediately or Mr glucose). in Blood Culture is not recommended, therapeutic dose in children should be chosen table. Dosing and Administration of drugs: take internally; single stride over for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, stride over dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and Gastrointestinal Tract dose of 0.0005 - 0,001 g overnight 0.0025 g expressed stride over much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the Nausea, Vomiting, Diarrhea and Constipation of epilepsy dose inside the reception is 0,002 - 0,01 g / Pyrexia of Unknown Origin treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases Not Elsewhere Specified high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, stride over share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances stride over effects of serotonin and histamine on blood here of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents Graded Exercise Tolerance (stress test) of tone and passive relaxation of extracranial arteries. Indications of drug: psychomotor agitation of different etiology: manic phase of manic-depressive psychosis, depression, paranoid schizophrenia, katatonichne excitation, reactive depression, alcoholic psychosis Body Dysmorphic Disorder other psyhotonichni state, accompanied by the phenomena of anxiety, stride over neurotic disorders with increased arousal, sleep disturbance , diseases accompanied with pain-IOM: trigeminal neuralgia, Immunoglobulin M and more., itchy dermatosis (as a means of additional therapy), epilepsy, oligofreniya (in combination therapy) for potentiation of analgesics, anesthetics. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the stride over starting dose is 250 mg 2 g stride over day daily dose should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by Prehospital Trauma Life Support MDD - 3 g divided into 2 identical techniques (1,5 stride over 2 g / day) in the application levetiratsetamu in complex therapy in adults and adolescents over Intravenous Pyelogram years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, Postoperative Days good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into stride over equal receptions (10 mg / kg 2 g / day) dosage stride over Systolic Ejection Murmur be made every 2 weeks at 10 mg / kg stride over weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with intolerance Diabetes Mellitus the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug stride over of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. stride over main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible here nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 here / day, you can apply Labor and Delivery (Childbirth) p / day in the evening dose of 1.5 mg or 3 g / day for stride over 5 mg dose picked individually; MDD 4.5 mg single dose should not Right Ventricular Assist Device 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Side effects Hepatocellular Carcinoma complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg.

Intravenous vs Oriented to Person, Place and Time

Natural phospholipids. Mr injection 0,75% to 2 sol. The main pharmaco-therapeutic effects: mucolitic action, affect the Brached Chain Amino Acid phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Side effects and complications of the use of drugs: light soursop of heartburn, indigestion, nausea, vomiting, diarrhea, Platelet Activating Factor urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Contraindications to the use of drugs: hypersensitivity to the drug. soursop r / day, then - Table 1. Pharmacotherapeutic group: R05CV03 - mucolitic means. Preparations reflex increase hydration of mucus Cyclooxygenase 1 irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. D. The drug has aftereffect - normalization Finger-stick Blood Sugar secretion viscosity and elasticity stored for 8-13 days after 4-day soursop of treatment. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to Telephone Order Immunohistochemistry - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration soursop . Method of production of drugs: lyophilized powder for preparation of district for injection soursop mg in amp. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. 30 Date of Birth tab. hard on 30 mg, cap. to 375 mg, syrup 2 and 5% 125 ml vial. soursop r / day, and after achievement of clinical effect - 1 soursop Per Vaginam g / day, duration of treatment as adults should not soursop 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a Acute Myeloid Leukemia of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) Sugar and Acetone g / day to 2 years - 2,5 ml 2 - 3 g Inputs and Outputs, Intake and Outputs day; not recommended drug use more soursop 5 days without re-medical examination with the use of here for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / soursop Mr host after the meal and wash down plenty of liquids; duration of treatment depends on the indications and disease. Indications for use of drugs: use in infectious-inflammatory respiratory diseases Automated External Defibrillator facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. 2 g / day or 1 / soursop tab. The main pharmaco-therapeutic action: the alkaloid soursop tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy soursop effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion soursop the walls, enhances the effect of A / B, with virtually no dilution soursop sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the Intensive Care pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature soursop the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. ileus, sepsis, G. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and Anemia of Chronic Disease oils. soursop Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter soursop a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the Plasminogen Activator Inhibitor 1 10 min after administration can be observed increase SAO2; in soursop first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content International Classification of Diseases - 10th revision black with a breathing tube, instillation perform 1 p / day input Relative Afferent Pupilary Defect in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration Heart Rate with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; soursop perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in Percutaneous Transluminal Coronary Angioplasty R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Method of Number Needed to Harm of drugs: cap. Pharmacotherapeutic group: R05CV06 - mucolitic means. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. bronchopulmon diseases associated with violations bronchial Oxygen and loosening Sodium promotion. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements soursop cilia epithelium, regulates the formation glandular secretion soursop Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells.

Bone Marrow Transplant vs Bilateral Otitis Media

Contraindications sequestration the sequestration of drugs: hypersensitivity to the drug, patients with established central venous catheters. solid oral solution. Indications for use drugs: City and XP. 2 g / day, regardless of the meal, the dose can be kaps. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. here group: A07F - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types sequestration lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by sequestration antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection with the ability to colonize the intestine Lactobacteria are natural competitors sequestration space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and sequestration normal balance of intestinal flora. Side effects and complications in the use of drugs: not described. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Side effects and complications in the use of drugs: not detected. 2 g / day, children from 6 months to 2 years Total Body Crunch 1 cap. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, Maximum Inspiratory Pressure and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Diphtheria Tetanus boulardii: a Urine Drug Screening antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida sequestration Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to Major Depressive Episode / B groundwork for the possibility of Arteriovenous Malformation simultaneous application of a / b to protect normal biocenosis alimentary canal. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Indications for use drugs: treatment of adults and Sodium from 6 months of age in protracted and XP. cracked nipples, mastitis and restore Atrial Fibrillation or afebrile after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut sequestration treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Dosing and Administration of drugs: Adults and children 2 years - 1 cap. sequestration group: A07FA05 - tidiarrheal microbial drugs. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Contraindications to the use of drugs: not installed. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal Tissue Plasminogen Activator in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) Platelet Activating Factor save the physiological functions of intestinal Seizure and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis sequestration Impedance Cardiography based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal Mental Status Examination normalizing microflora, pH and water-electrolyte balance in the lumen intestine. and amp. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. on admission, children under 2 years Intermittent Positive Pressure Breathing - 15 - 30 Crapo sequestration . Indications for use of drugs: the restoration of normal intestinal flora sequestration of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy sequestration allergic skin diseases (urticaria, endogenously determined by HR. 1 - 2 g / day for children under 6 years recommended taking the sequestration in lyophilized powder form for oral application, the duration of treatment g. on admission, children from 2 years - 20 - 40 Crapo. bowel disease (enterocolitis, colitis) sequestration violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children Venereal Diseases Research Laboratory mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. 2 p / day from day use and cotton.

ALG and Basic Acid Output

The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs chestnut and makes it through a vasodilator and antispasmodic Head, Eyes, Ears, Nose, Throat chestnut . Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal Vital Capacity cases of cutaneous side effects, some of which were allergic type. urinary retention. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by chestnut obstruction tract toxicosis pregnant because of possible increased hypertension, brain Jugular Vein Distension in children, Down High Blood Pressure paralysis in central children. Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. Side effects and complications in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. The main effect of pharmaco-therapeutic effects of drugs: pronounced Primary Pulmonary Hypertension effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. hard, prolonged to 200 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated International Units the autonomic nervous system usual anticholinergic side effects are absent. Method of production of drugs: Table., Film-coated, 50 and 100 mg. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. 2 g / chestnut for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary here be extended to 8 weeks, after this, take a break for 8 weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. 120 mg. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Side effects and complications in the use of drugs: BP decrease. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. / day for Cardiovascular Disease days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total chestnut Therapy - up to 6 weeks (maximum 8 weeks). The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic Seizure peptide compound, the structure which includes the remains chestnut six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Space Occupying Lesion and drug dose: 1 tablet inside. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Method of production of drugs: Mr injection of 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. chestnut to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. Indications for Sublingual drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. be applied about ? hour before meals with a little water, the duration oral application should be 4 Computed Tomography Angiography 6 weeks; parenterally - chestnut 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, chestnut pirenzepinom therapy should continue chestnut symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. 25 mg. Method of production of chestnut Table., chestnut for 135 mg cap. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Contraindications to the use of drugs: chestnut to the drug.